Benefits offered by microbial manufacturing, such as low production costs and faster development timelines, have led many innovators to adopt microbial fermentation for next generation biologics, offering lucrative opportunities for microbial CMOs / CDMOs. Within microbial fermentation market, service providers presently claim to have most of the microbial production capacity, driving innovators to outsource their